A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

September 30, 2015

Study Completion Date

October 31, 2015

Conditions
Autism Spectrum Disorders
Interventions
DRUG

Riluzole

50mg once daily (QD) for 12 weeks for participants 6-11 years old; 50mg twice daily (BID) for 12 weeks for participants 12-17 years old

DRUG

Placebo

Placebo comparator once daily (QD) for 12 weeks for participants 6-11 years old; Placebo comparator twice daily (BID) for 12 weeks for participants 12-17 years old

Trial Locations (3)

L8S 4K1

Offord Centre for Child Studies, Hamilton

N6A 5W9

Lawson Health Research Institute, London

M4G 1R8

Holland Bloorview Kids Rehabilitation Hospital, Toronto

All Listed Sponsors
collaborator

McMaster University

OTHER

collaborator

The Hospital for Sick Children

OTHER

collaborator

The University of Western Ontario

UNKNOWN

collaborator

Unity Health Toronto

OTHER

collaborator

University of Toronto

OTHER

lead

Holland Bloorview Kids Rehabilitation Hospital

OTHER

NCT01661855 - A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD | Biotech Hunter | Biotech Hunter